title: Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers.
abstract: In this issue, Madadi et al. report on interviews with codeine-prescribed breastfeeding mothers concerning preferences and attitudes toward receiving their CYP2D6 genotype and overall study findings. We address three sets of ethics questions raised by this article. Should genetic information be disclosed to research participants in genetic research? What should clinicians take into account when considering this genetic test in managing infant opioid toxicity risk? What conditions support or hinder the integration of genetic information into patient care?
authors.affiliation: Yale-New Haven Hospital, New Haven, Connecticut, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kurtz
authors.forename: P
authors.initials: P
authors.lastname: Black Golde
authors.forename: N
authors.initials: N
authors.lastname: Berlinger
mesh_terms: D001942:Breast Feeding; D003061:Codeine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D005260:Female; D005820:Genetic Testing / Q000941:ethics*; D005838:Genotype; D006801:Humans; D007223:Infant
chemical_list: D019389:Cytochrome P-450 CYP2D6; D003061:Codeine